What role did QVT Financial Investment Cayman Ltd. play in the ROIV share sales?

QVT Financial Investment Cayman Ltd. sold 1,438,163 Roivant Sciences Common Shares across several open-market transactions between June 26 and June 30, 2026. The entity held 13,689,166 shares afterward. Manchester is a shareholder of QVT FIC but has no voting or investment control over its securities.

Roivant Sciences (NASDAQ: ROIV) director records sale of 1,638,163 shares

Filing Impact

(Very High)

Filing Sentiment

(Very Negative)

Form Type

Rhea-AI Filing Summary

Roivant Sciences director Keith S. Manchester reported open-market sales totaling 1,638,163 Common Shares of Roivant Sciences Ltd. from June 26–30, 2026, at prices between $33.92 and $35.45 per share. The filing shows 200,000 shares sold from his direct holdings, leaving 1,748,403 shares held directly, and additional sales by QVT Financial Investment Cayman Ltd., which held 13,689,166 shares afterward. Manchester is a shareholder of QVT Financial Investment Cayman Ltd. but has no voting or investment control over it and disclaims beneficial ownership of those shares except for his pecuniary interest.

Insights

Director reports sizable net share sales while retaining large holdings.

Director Keith S. Manchester reported six open-market sale transactions in Roivant Sciences Ltd. Common Shares totaling 1,638,163 shares between June 26 and June 30, 2026. These are all non-derivative transactions coded "S", indicating straightforward open-market or private sales.

The filing separates 200,000 shares sold from Manchester’s direct holdings from 1,438,163 shares sold by QVT Financial Investment Cayman Ltd.. A footnote states he is a shareholder of this entity but has no voting or investment control and disclaims beneficial ownership beyond his pecuniary interest, which limits how directly these trades reflect his own portfolio decisions.

After the transactions, Manchester’s direct position is 1,748,403 shares, and QVT Financial Investment Cayman Ltd. shows 13,689,166 shares. The sales are material in absolute terms, but the remaining positions suggest continued substantial exposure. The filing does not reference any Rule 10b5-1 trading plan, so these appear as discretionary sales based on the disclosed information.

Insider Trade Summary

Net Seller: 1,638,163 shares ($56,444,076)

Net Sell 6 txns

Insider MANCHESTER KEITH S

Role null

Sold 1,638,163 shs ($56.44M)

Type	Security	Shares	Price	Value
Sale	Common Shares	12,380	$35.28	$437K
Sale	Common Shares	200,000	$35.45	$7.09M
Sale	Common Shares	200,000	$34.44	$6.89M
Sale	Common Shares	600,000	$34.59	$20.75M
Sale	Common Shares	300,783	$33.92	$10.20M
Sale	Common Shares	325,000	$34.07	$11.07M

Holdings After Transaction: Common Shares — 13,689,166 shares (Indirect, Held by QVT Financial Investment Cayman Ltd.); Common Shares — 1,748,403 shares (Direct, null)

Footnotes (1)

[object Object]

Key Figures

Total shares sold: 1,638,163 shares Direct shares sold: 200,000 shares Direct holdings after sale: 1,748,403 shares +4 more

7 metrics

Total shares sold 1,638,163 shares Net open-market sales from June 26–30, 2026

Direct shares sold 200,000 shares Common Shares sold directly on June 30, 2026 at $35.45

Direct holdings after sale 1,748,403 shares Common Shares held directly following June 30, 2026 transaction

Indirect shares sold by QVT FIC 1,438,163 shares Common Shares sold via QVT Financial Investment Cayman Ltd.

QVT FIC holdings after sales 13,689,166 shares Common Shares held by QVT Financial Investment Cayman Ltd. after June 30, 2026

Highest reported sale price $35.45 per share Direct sale of 200,000 Common Shares on June 30, 2026

Lowest reported sale price $33.92 per share Indirect sale of 300,783 Common Shares on June 26, 2026

Key Terms

open-market sale, Section 16, beneficial ownership, pecuniary interest, +1 more

5 terms

open-market sale financial

"transaction_action": "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Section 16 regulatory

"for purposes of Section 16 or for any other purpose"

Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.

beneficial ownership financial

"disclaims beneficial ownership of these securities except to the extent"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

pecuniary interest financial

"except to the extent of his pecuniary interest therein"

Common Shares financial

"The inclusion of these Common Shares in this report"

Common shares are the basic units of ownership in a company that give holders a claim on profits and a right to vote on key matters, like electing the board. Think of them as membership cards in a club: they let you share in successes and losses, but in a bankruptcy or liquidation they are paid after creditors and preferred shareholders, so their value can swing more and matters for assessing risk and potential return.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/30/2026 - 08:38 PM Accepted by SEC EDGAR 06/30/2026 - 08:38 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MANCHESTER KEITH S

(Last)

(First)

(Middle)

C/O ROIVANT SCIENCES LTD.

7TH FLOOR, 50 BROADWAY

(Street)

LONDON

UNITED KINGDOM

SW1H 0DB

(City)

(State)

(Zip)

UNITED KINGDOM

(Country)

2. Issuer Name and Ticker or Trading Symbol
Roivant Sciences Ltd. [ ROIV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Shares	06/26/2026		S		300,783	D	$33.92	14,826,546	I⁽¹⁾	Held by QVT Financial Investment Cayman Ltd.
Common Shares	06/26/2026		S		325,000	D	$34.07	14,501,546	I⁽¹⁾	Held by QVT Financial Investment Cayman Ltd.
Common Shares	06/29/2026		S		200,000	D	$34.44	14,301,546	I⁽¹⁾	Held by QVT Financial Investment Cayman Ltd.
Common Shares	06/29/2026		S		600,000	D	$34.59	13,701,546	I⁽¹⁾	Held by QVT Financial Investment Cayman Ltd.
Common Shares	06/30/2026		S		12,380	D	$35.28	13,689,166	I⁽¹⁾	Held by QVT Financial Investment Cayman Ltd.
Common Shares	06/30/2026		S		200,000	D	$35.45	1,748,403	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The reporting person is a shareholder of QVT Financial Investment Cayman Ltd. ("QVT FIC") but does not have any voting or investment control over QVT FIC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.

	/s/ Keith Manchester	06/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider activity did Roivant Sciences (ROIV) disclose in this Form 4?

Roivant Sciences reported that director Keith S. Manchester disclosed open-market sales totaling 1,638,163 Common Shares between June 26 and June 30, 2026. The trades included both his direct holdings and shares held through QVT Financial Investment Cayman Ltd., an entity associated with him.

How many Roivant Sciences (ROIV) shares did Keith S. Manchester sell directly?

Keith S. Manchester sold 200,000 Roivant Sciences Common Shares from his direct holdings at a price of $35.45 per share. After this transaction, he directly held 1,748,403 Roivant shares, indicating he retained a substantial personal position following the reported sale.

At what prices were the Roivant Sciences (ROIV) shares sold in these insider transactions?

The reported Roivant Sciences share sales occurred at prices ranging from $33.92 to $35.45 per share. Individual transactions included 200,000 shares at $35.45 directly and multiple indirect sales through QVT Financial Investment Cayman Ltd. at prices such as $34.07, $34.44, and $34.59.

How many Roivant Sciences (ROIV) shares does Keith S. Manchester hold after these transactions?

After the reported sales, Keith S. Manchester directly holds 1,748,403 Roivant Sciences Common Shares. Separately, QVT Financial Investment Cayman Ltd., in which he is a shareholder, holds 13,689,166 shares, though he disclaims beneficial ownership of those except for his pecuniary interest.

Does Keith S. Manchester control the Roivant shares held by QVT Financial Investment Cayman Ltd.?

According to the filing’s footnote, Manchester is a shareholder of QVT Financial Investment Cayman Ltd. but has no voting or investment control over that entity. He disclaims beneficial ownership of its Roivant shares except to the extent of his pecuniary interest in the securities.